Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Involvement of Breast Cancer Resistance Protein (BCRP/ABCG2) in the Biliary Excretion and Intestinal Efflux of Troglitazone Sulfate, the Major Metabolite of Troglitazone with a Cholestatic Effect

Junichi Enokizono, Hiroyuki Kusuhara and Yuichi Sugiyama
Drug Metabolism and Disposition February 2007, 35 (2) 209-214; DOI: https://doi.org/10.1124/dmd.106.012567
Junichi Enokizono
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroyuki Kusuhara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuichi Sugiyama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 35 no. 2 209-214
DOI 
https://doi.org/10.1124/dmd.106.012567
PubMed 
17093005

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received August 27, 2006
  • Accepted November 1, 2006
  • Published online January 23, 2007.

Article Versions

  • Earlier version (November 8, 2006 - 07:49).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Junichi Enokizono,
  2. Hiroyuki Kusuhara and
  3. Yuichi Sugiyama
  1. Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan
  1. Address correspondence to:
    Yuichi Sugiyama, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. E-mail: sugiyama{at}mol.f.u-tokyo.ac.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2006 to March 2021

AbstractFullPdf
Nov 2006430152
Dec 20066056
Jan 200761967
Feb 2007352775
Mar 2007201738
Apr 2007192933
May 2007143635
Jun 2007102318
Jul 2007101416
Aug 2007191725
Sep 20075614
Oct 200712825
Nov 200732025
Dec 2007787
Jan 20088713
Feb 2008121820
Mar 200873124
Apr 2008151724
May 200892129
Jun 200872022
Jul 200892612
Aug 2008162111
Sep 2008122214
Oct 20086912
Nov 200841721
Dec 20086148
Jan 200971118
Feb 20096820
Mar 2009161310
Apr 20098711
May 2009777
Jun 20096159
Jul 2009575
Aug 200961413
Sep 20091044
Oct 200991612
Nov 2009696
Dec 200915310
Jan 20103193
Feb 201025165
Mar 2010161820
Apr 2010131510
May 20102297
Jun 201020411
Jul 201013106
Aug 201022128
Sep 20101197
Oct 201012105
Nov 201014118
Dec 2010121310
Jan 201120711
Feb 201191210
Mar 2011151410
Apr 201112148
May 2011172214
Jun 2011181114
Jul 20111896
Aug 201115298
Sep 20111778
Oct 201127911
Nov 2011231215
Dec 2011191512
Jan 20121474
Feb 2012231515
Mar 2012261213
Apr 2012181010
May 2012441018
Jun 2012221011
Jul 201225815
Aug 2012141114
Sep 2012311017
Oct 2012231113
Nov 201227910
Dec 2012221010
Jan 201321136
Feb 2013342313
Mar 2013271513
Apr 2013152115
May 201327139
Jun 201312148
Jul 20131466
Aug 2013973
Sep 20132468
Oct 20131955
Nov 2013733
Dec 2013443
Jan 20141062
Feb 20149107
Mar 201410127
Apr 20141931
May 20141674
Jun 20141293
Jul 201417310
Aug 2014534
Sep 20141845
Oct 20141936
Nov 20141360
Dec 2014451
Jan 2015181113
Feb 20157102
Mar 20151694
Apr 20151664
May 20151154
Jun 201513114
Jul 2015151312
Aug 20151766
Sep 20151522
Oct 20151373
Nov 2015862
Dec 2015844
Jan 2016141012
Feb 2016584
Mar 2016538
Apr 201611125
May 2016756
Jun 20161574
Jul 20167918
Aug 20169159
Sep 2016765
Oct 20163183
Nov 20166103
Dec 201612110
Jan 201701810
Feb 20172153
Mar 2017094
Apr 20171132
May 20170143
Jun 20171161
Jul 2017271
Aug 20170354
Sep 20171239
Oct 20172235
Nov 201742010
Dec 201701311
Jan 20181172
Feb 20182205
Mar 20181187
Apr 20182192
May 20181153
Jun 20180101
Jul 20180116
Aug 201802515
Sep 2018082
Oct 20180276
Nov 201802111
Dec 20181752
Jan 20191226
Feb 2019401
Mar 2019343
Apr 2019722
May 2019630
Jun 20191014
Jul 2019702
Aug 20191401
Sep 20191311
Oct 20191500
Nov 20191400
Dec 20191363
Jan 2020822
Feb 20201521
Mar 2020745
Apr 20201010
May 20201122
Jun 20201000
Jul 2020412
Aug 20202011
Sep 2020911
Oct 20201005
Nov 2020823
Dec 2020932
Jan 202114112
Feb 202113176
Mar 2021400

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 35 (2)
Drug Metabolism and Disposition
Vol. 35, Issue 2
1 Feb 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Involvement of Breast Cancer Resistance Protein (BCRP/ABCG2) in the Biliary Excretion and Intestinal Efflux of Troglitazone Sulfate, the Major Metabolite of Troglitazone with a Cholestatic Effect
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Involvement of Breast Cancer Resistance Protein (BCRP/ABCG2) in the Biliary Excretion and Intestinal Efflux of Troglitazone Sulfate, the Major Metabolite of Troglitazone with a Cholestatic Effect

Junichi Enokizono, Hiroyuki Kusuhara and Yuichi Sugiyama
Drug Metabolism and Disposition February 1, 2007, 35 (2) 209-214; DOI: https://doi.org/10.1124/dmd.106.012567

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Involvement of Breast Cancer Resistance Protein (BCRP/ABCG2) in the Biliary Excretion and Intestinal Efflux of Troglitazone Sulfate, the Major Metabolite of Troglitazone with a Cholestatic Effect

Junichi Enokizono, Hiroyuki Kusuhara and Yuichi Sugiyama
Drug Metabolism and Disposition February 1, 2007, 35 (2) 209-214; DOI: https://doi.org/10.1124/dmd.106.012567
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Ozanimod human metabolism and Disposition
  • High-throughput Characterization of SLCO1B1 Variants of VUS.
  • Poria cocos triterpenes as bile acid transporter inhibitors
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics